Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
DIABETES THERAPY
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Oral Semaglutide Reduces HbA(1c) and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses
. 12:1099-1116.
2021
Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)
. 11:53-70.
2019
Identity
International Standard Serial Number (ISSN)
1869-6953
Electronic International Standard Serial Number (EISSN)
1869-6961
Other
journal abbreviation
DIABETES THER